Found: 3
Select item for more details and to access through your institution.
The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1221605
- By:
- Publication type:
- Article
Dose-Dense Adjuvant Chemotherapy in Early Breast Cancer Patients: Results From a Randomized Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 23, p. 1724, doi. 10.1093/jnci/dji398
- By:
- Publication type:
- Article
Receptor Activator of NF-kB (RANK) Expression in Primary Tumors Associates with Bone Metastasis Occurrence in Breast Cancer Patients.
- Published in:
- PLoS ONE, 2011, v. 6, n. 4, p. 1, doi. 10.1371/journal.pone.0019234
- By:
- Publication type:
- Article